Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $939.49 billion, total revenue of $174.23 billion and a weighted average PE ratio of 50.72.
Market Cap
939.49B
Revenue
174.23B
Profits
18.52B
PE Ratio
50.72
Profit Margin
10.63%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 260.66B | 2.56% | 1,723,155 | 47.35B |
| 2 | DHR | Danaher Corporation | 163.26B | 3.57% | 4,545,429 | 25.61B |
| 3 | NTRA | Natera, Inc. | 60.39B | 3.21% | 444,846 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 49.98B | 2.46% | 735,961 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 45.26B | 2.67% | 541,811 | 16.98B |
| 6 | WAT | Waters Corporation | 44.75B | 2.85% | 262,455 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 43.55B | -0.91% | 125,692 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 42.85B | 5.92% | 845,941 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 33.38B | 1.96% | 33,727 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 26.30B | 0.48% | 280,680 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 26.15B | -0.20% | 119,448 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 22.79B | 4.43% | 817,848 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.55B | 6.76% | 301,141 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 17.64B | 1.33% | 622,763 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.18B | 7.47% | 715,599 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 14.44B | 7.48% | 426,028 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.93B | -1.78% | 3,693,737 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 5.88B | 5.59% | 218,402 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.47B | -0.14% | 55,624 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.11B | -0.17% | 536,269 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.96B | 1.58% | 90,766 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.06B | 4.22% | 684,116 | 308.08M |
| 23 | CDNA | CareDx, Inc. | 3.72B | 4.04% | 552,522 | 458.09M |
| 24 | VCYT | Veracyte, Inc. | 3.65B | 1.38% | 162,067 | 561.90M |
| 25 | NEO | NeoGenomics, Inc. | 2.19B | 2.65% | 411,962 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.10B | 2.40% | 224,649 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.71B | 0.38% | 1,099,049 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.50B | -0.43% | 160,492 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.21B | -2.11% | 1,056,251 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.05B | 3.89% | 100,466 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 555.26M | -0.74% | 34,801 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 536.59M | 1.26% | 1,206,808 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 250.06M | -0.71% | 29,248 | 102.94M |
| 34 | XGN | Exagen Inc. | 189.20M | 5.40% | 87,637 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 139.21M | 4.27% | 13,818 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 99.32M | 0.17% | 127,911 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 89.11M | -0.93% | 119,552 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 38.44M | -1.15% | 34,709 | 27.20M |
| 39 | MDXH | MDxHealth SA | 20.12M | 8.49% | 1,633,425 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.09M | 5.72% | 8,751 | - |
| 41 | XWEL | XWELL, Inc. | 6.61M | 17.90% | 62,732 | 28.28M |
| 42 | ADVB | Advanced Biomed Inc. | 6.11M | -2.63% | 13,520 | 127.64K |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.58M | -2.46% | 35,262 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.24M | -7.29% | 36,724 | 466.30K |